MedTrace Logo

NRM on Vascular Perfusion in Healthy Adults

NCT06345443 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-03-18

No results posted yet for this study

Summary

The purpose of this study is to better understand the effects of nicotinamide riboside supplement in overall cardiovascular health in healthy adults.

Conditions

  • Vascular Stiffness

Interventions

DIETARY_SUPPLEMENT

Nicotinamide Riboside Malate

Active supplement.

OTHER

Placebo

Placebo

Sponsors & Collaborators

Principal Investigators

  • Ryan Hurt, MD, PhD · Mayo Clinic

  • Brent Bauer, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-25
Primary Completion
2026-09-30
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06345443 on ClinicalTrials.gov